dor_id: 4119448

506.#.#.a: Público

590.#.#.d: Los artículos enviados a la revista "Contaduría y Administración", se juzgan por medio de un proceso de revisión por pares

510.0.#.a: Consejo Nacional de Ciencia y Tecnología (CONACyT); Sistema Regional de Información en Línea para Revistas Científicas de América Latina, el Caribe, España y Portugal (Latindex); Scientific Electronic Library Online (SciELO); SCOPUS, SCImago Journal Rank (SJR)

561.#.#.u: https://www.fca.unam.mx/

650.#.4.x: Ciencias Sociales y Económicas

336.#.#.b: article

336.#.#.3: Artículo de Investigación

336.#.#.a: Artículo

351.#.#.6: http://www.cya.unam.mx/index.php/cya/index

351.#.#.b: Contaduría y Administración

351.#.#.a: Artículos

harvesting_group: RevistasUNAM

270.1.#.p: Revistas UNAM. Dirección General de Publicaciones y Fomento Editorial, UNAM en revistas@unam.mx

590.#.#.c: Open Journal Systems (OJS)

270.#.#.d: MX

270.1.#.d: México

590.#.#.b: Concentrador

883.#.#.u: https://revistas.unam.mx/catalogo/

883.#.#.a: Revistas UNAM

590.#.#.a: Coordinación de Difusión Cultural

883.#.#.1: https://www.publicaciones.unam.mx/

883.#.#.q: Dirección General de Publicaciones y Fomento Editorial

850.#.#.a: Universidad Nacional Autónoma de México

856.4.0.u: http://www.cya.unam.mx/index.php/cya/article/view/577/575

100.1.#.a: Chukwuogor Ndu, Chiaku

524.#.#.a: Chukwuogor Ndu, Chiaku (2005). Factors Contributing to the Categorization of Worst Performing Companies. The Case of Protein Sesign Labs, Inc. (PDLI). Contaduría y Administración; Núm. 217. Recuperado de https://repositorio.unam.mx/contenidos/4119448

245.1.0.a: Factors Contributing to the Categorization of Worst Performing Companies. The Case of Protein Sesign Labs, Inc. (PDLI)

502.#.#.c: Universidad Nacional Autónoma de México

561.1.#.a: Facultad de Contaduría y Administración, UNAM

264.#.0.c: 2005

264.#.1.c: 2009-10-05

653.#.#.a: Financial performance; worst performing; profitability; return on equity; profit margin; correlation coefficient; expenditure; current ratio; liquidity; cash flow; coverage ratios; efficiency ratios; total asset turnover; solvency; research and development

506.1.#.a: La titularidad de los derechos patrimoniales de esta obra pertenece a las instituciones editoras. Su uso se rige por una licencia Creative Commons BY 4.0 Internacional, https://creativecommons.org/licenses/by/4.0/legalcode.es, fecha de asignación de la licencia 2009-10-05, para un uso diferente consultar al responsable jurídico del repositorio por medio del correo electrónico revista_cya@fca.unam.mx

884.#.#.k: http://www.cya.unam.mx/index.php/cya/article/view/577

001.#.#.#: oai:cya.www.revistas-conacyt.unam.mx:article/577

041.#.7.h: spa

520.3.#.a: This paper examines the financial performance of one of the 2002 worst performing company, protein design labs inc. For the period 1993 to 2002. Findings indicate that the profitability ratios such as return on equity, return on assets and net profit margin were negative for most of the years between 1993 and 2004. The pearson"s correlation coefficient between protein design"s net sales and r & d expenditure for the period 1993 to 2004 is .85 and is significant at 1 percent level. Between 1996 and 2004, annual expenditures on research and development exceeded the annual net sales. The current ratio of protein design ranges between 10:1 and 58:1 in 1998 and 2000 respectively. Protein design is by far more liquid than its competitors. The cash flow adequacy and cash interest coverage ratios indicate that protein design was extremely liquid for most of the period. Cash flows from financing were responsible for healthy cash flow situation. The efficiency ratios were poor. They show that during the period, protein design had the lowest total asset turnover when compared to its immediate competitors such as corixa and medummune. Despite poor earnings generating performance, protein design is among the top emerging pharmaceutical companies attracting high corporate alliances and investors" confidence. With a new chief executive, a new president of research and development, and a strong balance sheet, protein design labs inc is expecting greater profitability in the future

773.1.#.t: Contaduría y Administración; Núm. 217 (2005)

773.1.#.o: http://www.cya.unam.mx/index.php/cya/index

046.#.#.j: 2021-10-20 00:00:00.000000

022.#.#.a: ISSN electrónico: 2448-8410; ISSN impreso: 0186-1042

310.#.#.a: Trimestral

264.#.1.b: Facultad de Contaduría y Administración, UNAM

758.#.#.1: http://www.cya.unam.mx/index.php/cya/index

doi: https://doi.org/10.22201/fca.24488410e.2005.577

handle: 20bf51bfcca7ab4f

harvesting_date: 2021-06-14 11:43:00.0

245.1.0.b: Factors contributing to the categorization of worst performing companies. the case of protein sesign labs, inc. (pdli)

last_modified: 2023-03-22 16:00:00

license_url: https://creativecommons.org/licenses/by/4.0/legalcode.es

license_type: by

No entro en nada

No entro en nada 2

Artículo

Factors Contributing to the Categorization of Worst Performing Companies. The Case of Protein Sesign Labs, Inc. (PDLI)

Chukwuogor Ndu, Chiaku

Facultad de Contaduría y Administración, UNAM, publicado en Contaduría y Administración, y cosechado de Revistas UNAM

Licencia de uso

Procedencia del contenido

Entidad o dependencia
Facultad de Contaduría y Administración, UNAM
Revista
Repositorio
Contacto
Revistas UNAM. Dirección General de Publicaciones y Fomento Editorial, UNAM en revistas@unam.mx

Cita

Chukwuogor Ndu, Chiaku (2005). Factors Contributing to the Categorization of Worst Performing Companies. The Case of Protein Sesign Labs, Inc. (PDLI). Contaduría y Administración; Núm. 217. Recuperado de https://repositorio.unam.mx/contenidos/4119448

Descripción del recurso

Autor(es)
Chukwuogor Ndu, Chiaku
Tipo
Artículo de Investigación
Área del conocimiento
Ciencias Sociales y Económicas
Título
Factors Contributing to the Categorization of Worst Performing Companies. The Case of Protein Sesign Labs, Inc. (PDLI)
Fecha
2009-10-05
Resumen
This paper examines the financial performance of one of the 2002 worst performing company, protein design labs inc. For the period 1993 to 2002. Findings indicate that the profitability ratios such as return on equity, return on assets and net profit margin were negative for most of the years between 1993 and 2004. The pearson"s correlation coefficient between protein design"s net sales and r & d expenditure for the period 1993 to 2004 is .85 and is significant at 1 percent level. Between 1996 and 2004, annual expenditures on research and development exceeded the annual net sales. The current ratio of protein design ranges between 10:1 and 58:1 in 1998 and 2000 respectively. Protein design is by far more liquid than its competitors. The cash flow adequacy and cash interest coverage ratios indicate that protein design was extremely liquid for most of the period. Cash flows from financing were responsible for healthy cash flow situation. The efficiency ratios were poor. They show that during the period, protein design had the lowest total asset turnover when compared to its immediate competitors such as corixa and medummune. Despite poor earnings generating performance, protein design is among the top emerging pharmaceutical companies attracting high corporate alliances and investors" confidence. With a new chief executive, a new president of research and development, and a strong balance sheet, protein design labs inc is expecting greater profitability in the future
Tema
Financial performance; worst performing; profitability; return on equity; profit margin; correlation coefficient; expenditure; current ratio; liquidity; cash flow; coverage ratios; efficiency ratios; total asset turnover; solvency; research and development
Idioma
spa
ISSN
ISSN electrónico: 2448-8410; ISSN impreso: 0186-1042

Enlaces